| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,135 |
9,185 |
$776K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,341 |
3,414 |
$412K |
| 99199 |
Unlisted special service, procedure or report |
68,930 |
39,133 |
$391K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,871 |
1,484 |
$159K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,723 |
1,387 |
$150K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
851 |
676 |
$120K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,967 |
2,244 |
$112K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,152 |
908 |
$108K |
| 99442 |
|
1,989 |
1,580 |
$101K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,980 |
3,141 |
$74K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
886 |
638 |
$66K |
| D0145 |
Oral evaluation for a patient under three years of age |
1,424 |
1,181 |
$46K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,535 |
1,684 |
$34K |
| D1206 |
Topical application of fluoride varnish |
1,437 |
1,184 |
$20K |
| 92552 |
|
4,209 |
3,280 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,150 |
976 |
$15K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
266 |
203 |
$10K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
603 |
435 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
658 |
256 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,089 |
765 |
$7K |
| 92567 |
|
498 |
421 |
$6K |
| 81002 |
|
3,700 |
2,818 |
$6K |
| 96127 |
|
1,505 |
1,245 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
493 |
412 |
$5K |
| 99422 |
|
90 |
82 |
$4K |
| 90474 |
|
187 |
133 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
32 |
28 |
$3K |
| 90686 |
|
1,504 |
1,147 |
$2K |
| 99173 |
|
4,305 |
3,362 |
$2K |
| 90734 |
|
105 |
90 |
$993.89 |
| 0072A |
|
16 |
12 |
$808.58 |
| 99441 |
|
24 |
19 |
$798.46 |
| 0071A |
|
14 |
12 |
$786.28 |
| 90651 |
|
66 |
49 |
$751.85 |
| 90473 |
|
43 |
37 |
$702.41 |
| 90461 |
|
94 |
89 |
$662.20 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
12 |
$596.51 |
| 90688 |
|
36 |
34 |
$428.40 |
| 90660 |
|
31 |
27 |
$178.08 |
| 94664 |
|
473 |
397 |
$155.82 |
| 90715 |
|
12 |
12 |
$144.54 |
| 90656 |
|
26 |
26 |
$127.88 |
| 90672 |
|
119 |
113 |
$118.20 |
| 90698 |
|
199 |
154 |
$105.50 |
| 90633 |
|
261 |
218 |
$36.88 |
| 96161 |
|
14 |
13 |
$18.70 |
| 90670 |
|
704 |
489 |
$0.00 |
| 90710 |
|
17 |
13 |
$0.00 |
| 90685 |
|
123 |
106 |
$0.00 |
| 90680 |
|
184 |
130 |
$0.00 |
| 90744 |
|
103 |
90 |
$0.00 |
| 91307 |
|
38 |
30 |
$0.00 |
| 90657 |
|
34 |
33 |
$0.00 |